ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.65
0.48%
US Tech 100
18,318.00
0.95%
S&P 500
5,304.72
0.70%
US Dollar vs CAD
1.36715
0.00%
Bitcoin
69,158.98
-0.15%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Seres Therapeutics Inc (MCRB)

  7. Seres Therapeutics Inc (MCRB) News

MCRB

Seres Therapeutics (MCRB)

Seres Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MCRB
DateTimeSourceHeadlineSymbolCompany
05/17/20247:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
05/17/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
05/17/20247:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
05/17/20247:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
05/17/20247:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
05/08/20249:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MCRBSeres Therapeutics Inc
05/08/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
05/08/20246:00AMBusiness WireSeres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
05/07/20244:18PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
05/06/20243:01PMBusiness WireSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MCRBSeres Therapeutics Inc
05/06/20248:30AMBusiness WireSeres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024NASDAQ:MCRBSeres Therapeutics Inc
04/09/20246:00AMBusiness WireSeres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCTNASDAQ:MCRBSeres Therapeutics Inc
03/28/20246:00AMBusiness WireSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MCRBSeres Therapeutics Inc
03/19/20246:00AMBusiness WireSeres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MCRBSeres Therapeutics Inc
03/05/20249:18AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MCRBSeres Therapeutics Inc
03/05/20249:13AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MCRBSeres Therapeutics Inc
03/05/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
03/05/20246:00AMBusiness WireSeres Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
03/05/20245:05AMIH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:MCRBSeres Therapeutics Inc
02/28/20246:00AMBusiness WireSeres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024NASDAQ:MCRBSeres Therapeutics Inc
02/27/20246:00AMBusiness WireSeres Therapeutics to Participate in Cowen 44th Annual Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
02/26/20246:06AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
02/26/20246:00AMBusiness WireSeres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David ArkowitzNASDAQ:MCRBSeres Therapeutics Inc
02/23/20243:05PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
02/16/20248:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MCRB

Your Recent History

NASDAQ
RNAZ
TransCode Therapeutics
NASDAQ
DJT
Trump Media and Technology
USOTC
FNMA
Fannie Mae (QB)
NYSE
GME
GameStop
USOTC
RONN
Ronn Motor (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
MGON
Megola (PK)
USOTC
DPLS
DarkPulse (PK)
NASDAQ
NVDA
NVIDIA
NASDAQ
RVNC
Revance Therapeutics
NASDAQ
AVXL
Anavex Life Sciences
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NLST
Netlist (QB)
NYSE
AMC
AMC Entertainment
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved